Multi-Vitamin Elite FAQ

The premise is chronobiological. Activator nutrients — B-complex, methylated B12 and folate, choline, polyphenols — support catecholamine synthesis, mitochondrial substrate availability, and oxidative metabolism that aligns with the waking arc. Mineral cofactors — particularly magnesium and calcium — support GABA-ergic tone, parathyroid axis, and overnight bone turnover. Splitting the dose is not strictly necessary for nutritional sufficiency, but the clinical observation is that some patients sleep better on the PM mineral profile and feel steadier energy on the AM activator profile than they did on a single morning multi.

Multi-Vitamin Elite uses L-5-methyltetrahydrofolate (the active circulating form) rather than folic acid, and methylcobalamin rather than cyanocobalamin. The doses are physiologic (400-800 mcg methylfolate range, 200-400 mcg methylcobalamin range) rather than the pharmacologic doses some MTHFR-targeted products use. For patients with known MTHFR C677T or A1298C variants and inadequate response to folic acid, the methylated forms are reasonable. For patients without methylation-genotype context, the methylated forms are not harmful but also not clinically necessary.

Baseline and 12-week follow-up: serum B12, serum or RBC folate, 25(OH)D, RBC magnesium, ferritin, complete blood count, basic metabolic panel. Homocysteine if methylation status is clinically relevant. The about page lists the standard tracking panel, and the practitioner review covers the lab-monitoring approach in more detail.

Green-tea catechins (EGCG and related polyphenols) and quercetin have moderate evidence for metabolic and cardiovascular effects at the doses present in Multi-Vitamin Elite. These are not pharmacologic doses and the formula is not intended as a polyphenol intervention; the polyphenols are present as adjuncts. Patients seeking a clinical polyphenol dose should consider a dedicated formulation.

Warfarin (vitamin K2 in the P.M. bottle directly antagonizes — requires INR monitoring and disclosure to the anticoagulation clinic); levothyroxine and thyroid replacement (separate dosing by 4+ hours due to mineral chelation); bisphosphonates (separate by 2 hours from the P.M. mineral load); tetracycline and fluoroquinolone antibiotics (separate by 2-4 hours); methotrexate (folate-antagonism concern — discuss with rheumatology or oncology); MAO inhibitors (theoretical concern with the green-tea polyphenols — low clinical significance at this dose).

Adults seeking a comprehensive multivitamin floor with active-form B vitamins, NSF Certified for Sport quality control, methylation-aware formulation, and willingness to take a six-capsule split daily dose. Particularly well-suited to performance-oriented patients, MTHFR-aware patients, and patients with prior folic-acid-related reactions. Less well-suited to patients who want single-dose simplicity, pregnant or lactating women (use Thorne Basic Prenatal instead), and patients on warfarin without anticoagulation-clinic coordination.

Pregnancy and lactation (the folate dose is below the prenatal target). Active hemochromatosis (formula is iron-free, which is correct here, but the patient should be on a hemochromatosis-specific approach). Patients who will not commit to taking the formula with food. Patients with severe kidney disease, where the mineral load warrants nephrology review. Patients seeking pharmacologic methylation dosing for a specific genetic protocol.

This practitioner-written review covers the dosing observations, lab-monitoring approach, methylation-titration framework, and patient-profile fit in detail.